ReWalk Robotics (NASDAQ:LFWD) Announces Quarterly Earnings Results

ReWalk Robotics (NASDAQ:LFWD) released its quarterly earnings data on Thursday. The company reported ($0.50) EPS for the quarter, beating the consensus estimate of ($0.53) by $0.03, Zacks reports. The business had revenue of $6.71 million during the quarter, compared to the consensus estimate of $6.71 million. ReWalk Robotics had a negative net margin of 102.03% and a negative return on equity of 39.72%. During the same quarter in the prior year, the firm earned ($0.35) EPS. ReWalk Robotics updated its FY 2024 guidance to EPS.

ReWalk Robotics Trading Down 8.6 %

NASDAQ LFWD traded down $0.35 on Friday, hitting $3.72. 73,515 shares of the company’s stock traded hands, compared to its average volume of 44,008. The firm’s 50-day moving average price is $3.97 and its two-hundred day moving average price is $4.84. The firm has a market capitalization of $32.44 million, a PE ratio of -1.20 and a beta of 2.06. ReWalk Robotics has a 1-year low of $3.00 and a 1-year high of $9.10.

Analyst Ratings Changes

Several research analysts have commented on LFWD shares. Lake Street Capital raised shares of ReWalk Robotics to a “strong-buy” rating in a research note on Monday, June 24th. HC Wainwright lifted their target price on ReWalk Robotics from $9.00 to $13.00 and gave the company a “buy” rating in a research report on Friday.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.